Biotech Analyst Hsieh discusses recent initiation of coverage for Lantheus (LNTH) and RayzeBio (RYZB) two radiopharmaceutical companies on an Analyst/Industry conference call to be held on October 12 at 12:30 pm. Webcast Link
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LNTH:
- William Blair biotech analyst to hold an analyst/industry conference call
- Lantheus program validated by Point Biopharma buyout, says Mizuho
- Eli Lilly deal for Point puts radiopharma names in spotlight
- JMP Securities remains bullish on Lantheus after Lilly’s acquisition of Point Biopharma
- Point Biopharma deal reads positively to radiopharma names, says B. Riley